NCT06416800View on ClinicalTrials.gov

A Study to Assess the Effect of Povorcitinib on Digoxin, Rosuvastatin, and Metformin Pharmacokinetics and the Effect of Probenecid on Povorcitinib Pharmacokinetics When Administered Orally to Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

June 19, 2024

Primary Completion Date

January 15, 2025

Study Completion Date

January 15, 2025

Conditions
Healthy Participants
Interventions
DRUG

Digoxin

Oral; Tablet

DRUG

Rosuvastatin

Oral; Tablet

DRUG

Metformin

Oral; Tablet

DRUG

Povorcitinib

Oral; Tablet

DRUG

Probenecid

Oral; Tablet

Trial Locations (1)

75247

Fortrea Clinical Research Unit, Dallas

Sponsors

Lead Sponsor

Incyte Corporation
All Listed Sponsors
lead

Incyte Corporation

INDUSTRY